Skip to main content
. 2022 Jan 29;14:7. doi: 10.1186/s13099-022-00479-z

Table 1.

Clinical and demographic characteristics of hospitalized patients with CDI patients, stratified by mortality

No death within 30 days, N (%) Death within 30 days, N (%) p value
BMI
< 20 519 (14.9%) 39 (10.5%) 0.32
20–25 1175 (33.8%) 135 (36.2%)
25–30 920 (26.5%) 108 (29.0%)
30–35 490 (14.1%) 49 (13.1%)
35–40 213 (6.1%) 22 (5.9%)
40–45 92 (2.6%) 10 (2.7%)
> 45 69 (2.0%) 10 (2.7%)
Sex
Female 1830 (52.6%) 194 (52.0%) 0.82
Male 1648 (47.4%) 179 (48.0%)
Age
18–55 years 1102 (31.7%) 56 (15.0%)  < 0.01
56–75 years 1522 (43.8%) 180 (48.3%)
≥ 76 years 854 (24.6%) 137 (36.7%)
Race/ethnicity
Black 356 (10.2%) 37 (9.9%) 1.00
Hispanic 385 (11.1%) 41 (11.0%)
White 1930 (55.5%) 207 (55.5%)
Other 807 (23.2%) 88 (23.6%)
Charlson comorbidity index
0–3 points 1439 (41.4%) 62 (16.6%)  < 0.01
4–6 points 1682 (48.4%) 249 (66.8%)
> 7 points 357 (10.3%) 62 (16.6%)
Vital signs
Temperature < 35, > 38 °C 578 (24.7%) 98 (41.0%)  < 0.01
Heart rate > 100 beats/min 1728 (56.5%) 247 (77.4%)  < 0.01
MAP < 65 mmHg 940 (30.9%) 193 (62.1%)  < 0.01
Lab values
WBC count > 15 × 103/μL 1100 (31.6%) 208 (55.8%)  < 0.01
Hematocrit < 37.2% 2375 (91.2%) 308 (96.9%)  < 0.01
Platelet count < 156 × 103/μL 1302 (37.4%) 209 (56.0%)  < 0.01
Total bilirubin > 1.3 mg/dL 308 (14.0%) 86 (33.1%)  < 0.01
Albumin < 3 g/dL 1306 (44.4%) 241 (70.5%)  < 0.01
Creatinine > 1.5 mg/dL 1087 (31.4%) 218 (58.4%)  < 0.01
Hospitalization
Vasopressor use 533 (15.3%) 140 (37.5%)  < 0.01
ICU stay 914 (26.3%) 208 (55.8%)  < 0.01

Baseline characteristics of patients with Clostridioides difficile infection (n = 3851), stratified based on death within 30 days

CDI, Clostridioides difficile infection; BMI, body mass index; MAP, mean arterial pressure; WBC, white blood cell; ICU, intensive care unit